LeMaitre Vascular (LMAT) Earnings Date, Estimates & Call Transcripts $89.52 +0.67 (+0.75%) (As of 12:58 PM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateNov. 6EstimatedActual EPS (Aug. 1) $0.52 Beat By $0.05 Consensus EPS (Aug. 1) $0.47 Conference Call TranscriptConference Call AudioEarnings Press ReleaseEarnings Slide Deck Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueLMAT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.LMAT Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto 101 MediaThis Crypto Is Set to Explode in SeptemberWith thousands of cryptocurrencies out there, it's crucial to focus on the ONE that has the potential to make HUGE gains. Now, I'm about to reveal the #1 crypto for September 2024. Go here to get full details on this crypto now. LeMaitre Vascular Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20241$0.40$0.40$0.400.360 - 0.410Q2 20241$0.47$0.47$0.470.450 - 0.500Q3 20241$0.40$0.40$0.400.420 - 0.460Q4 20242$0.41$0.43$0.42 FY 20245$1.68$1.70$1.69 Q1 20252$0.44$0.50$0.47 Q2 20252$0.51$0.53$0.52 Q3 20252$0.44$0.49$0.47 Q4 20252$0.47$0.52$0.50 FY 20258$1.86$2.04 $1.95LMAT Earnings Date and InformationLeMaitre Vascular last posted its quarterly earnings data on August 1st, 2024. The medical instruments supplier reported $0.52 earnings per share for the quarter, topping the consensus estimate of $0.47 by $0.05. The business earned $55.85 million during the quarter, compared to analysts' expectations of $54.98 million. Its quarterly revenue was up 11.4% compared to the same quarter last year. LeMaitre Vascular has generated $1.51 earnings per share over the last year ($1.51 diluted earnings per share) and currently has a price-to-earnings ratio of 59.3. Earnings for LeMaitre Vascular are expected to grow by 12.97% in the coming year, from $1.85 to $2.09 per share. LeMaitre Vascular has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 6th, 2024 based off prior year's report dates.Read More LeMaitre Vascular Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 11/6/2024(Estimated)------- 8/1/2024Q2 2024$0.47$0.52+$0.05$0.52$54.98 million$55.85 million 5/2/2024Q1 2024$0.39$0.44+$0.05$0.44$51.50 million$53.48 million 2/27/2024Q4 2023$0.36$0.38+$0.02$0.38$49.01 million$48.90 million 11/1/2023Q3 2023$0.31$0.33+$0.02$0.33$47.58 million$47.40 million 8/1/2023Q2 2023$0.32$0.37+$0.05$0.38$48.29 million$50.12 million 5/2/2023Q1 2023$0.25$0.27+$0.02$0.27$43.54 million$47.08 million Why You Should NOT Trade This Market (Ad)You'll be interested in our 5-Day Options Trading Challenge, starting September 23. So, what makes this different from every other options research you may have seen? Well, for starters... most of them want you to first BUY their service... which is usually thousands of dollars...Just click here to get the full details on the 5-Day Options Trading Challenge, before this offer go2/23/2023Q4 2022$0.26$0.25($0.01)$0.25$40.99 million$41.00 million 10/27/2022Q3 2022$0.28$0.25($0.03)$0.25$40.13 million$39.03 million 7/28/2022Q2 2022$0.32$0.29($0.03)$0.42$41.26 million$42.11 million 4/28/2022Q1 2022$0.28$0.27($0.01)$0.27$38.65 million$39.56 million 2/24/2022Q4 2021$0.31$0.28($0.03)$0.28$39.70 million$39.50 million 10/28/2021Q3 2021$0.33$0.30($0.03)$0.30$39.05 million$38.37 million 7/29/2021Q2 2021$0.34$0.40+$0.06$0.40$40.70 million$40.67 million 4/29/2021Q1 2021$0.28$0.28-$0.28$35.55 million$35.88 million 2/25/2021Q4 2020$0.31$0.34+$0.03$0.34$35.87 million$37.55 million 10/29/2020Q3 2020$0.19$0.37+$0.18$0.37$31.62 million$36.42 million 7/23/2020Q2 2020$0.01$0.17+$0.16$0.17$15.58 million$24.85 million 4/30/2020Q1 2020$0.16$0.16-$0.16$30.50 million$30.55 million 2/6/2020Q4 2019$0.23$0.23-$0.23$30.44 million$30.20 million 10/23/2019Q3$0.21$0.25+$0.04$0.25$28.15 million$29.10 million LeMaitre Vascular Earnings - Frequently Asked Questions When is LeMaitre Vascular's earnings date? LeMaitre Vascular has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 6th, 2024 based off last year's report dates. Learn more on LMAT's earnings history. What guidance has LeMaitre Vascular issued on next quarter's earnings? LeMaitre Vascular updated its third quarter 2024 earnings guidance on Thursday, August, 1st. The company provided EPS guidance of 0.420-0.460 for the period, compared to the consensus estimate of 0.420. The company issued revenue guidance of $52.7 million-$54.7 million, compared to the consensus revenue estimate of $52.4 million. Did LeMaitre Vascular beat their earnings estimates last quarter? In the previous quarter, LeMaitre Vascular (NASDAQ:LMAT) reported $0.52 earnings per share (EPS) to beat the analysts' consensus estimate of $0.47 by $0.05. Learn more on analysts' earnings estimate vs. LMAT's actual earnings. How can I listen to LeMaitre Vascular's earnings conference call? The conference call for LeMaitre Vascular's latest earnings report can be listened to online. Listen to Conference Call How can I read LeMaitre Vascular's conference call transcript? The conference call transcript for LeMaitre Vascular's latest earnings report can be read online. Read Transcript How much revenue does LeMaitre Vascular generate each year? LeMaitre Vascular (NASDAQ:LMAT) has a recorded annual revenue of $205.62 million. How much profit does LeMaitre Vascular generate each year? LeMaitre Vascular (NASDAQ:LMAT) has a recorded net income of $30.10 million. LMAT has generated $1.51 earnings per share over the last four quarters. What is LeMaitre Vascular's price-to-earnings ratio? LeMaitre Vascular (NASDAQ:LMAT) has a trailing price-to-earnings ratio of 59.29 and a forward price-to-earnings ratio of 48.39. The price/earnings-to-growth ratio is 2.28. What is LeMaitre Vascular's EPS forecast for next year? LeMaitre Vascular's earnings are expected to grow from $1.85 per share to $2.09 per share in the next year, which is a 12.97% increase. More Earnings Resources from MarketBeat Related Companies: VAPO Earnings GKOS Earnings INSP Earnings MMSI Earnings ICUI Earnings PRCT Earnings HAE Earnings AXNX Earnings TNDM Earnings NARI Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GameStop: Earnings Won’t Save It, Dilution Points to TroubleIs Merck Stock Undervalued After Its Colossal Earnings Growth?Polestar Lives to Fight Another Day After Q2 EarningsWhy NVIDIA’s Earnings Point to a Bullish Future for Pure StorageDoes A&F's Q2 Earnings Win Point to a Strong Holiday Season?Salesforce Beats Earnings, Raises Full-Year Profit OutlookDon’t Count Out CrowdStrike Yet: Key Insights from Q2 Earnings This page (NASDAQ:LMAT) was last updated on 9/19/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThis diversified cannabis pioneer could make huge moves soonThe cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start ...Greenlane | SponsoredKamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppe...Paradigm Press | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredDump Nvidia, Apple, and Tesla Before It’s Too LateThe financial world is on high alert. Billionaires like Warren Buffett, Jeff Bezos, and Elon Musk are dumpi...InvestorPlace | SponsoredThe $15 "Insider Secret" That Could Save Your RetirementWhat if I told you there's a $15 stock that a billionaire insider just poured $47 MILLION into? That's righ...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding LeMaitre Vascular, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share LeMaitre Vascular With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.